Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns by unknown
Akoachere et al. BMC Research Notes 2012, 5:219
http://www.biomedcentral.com/1756-0500/5/219SHORT REPORT Open AccessEtiologic profile and antimicrobial susceptibility of
community-acquired urinary tract infection in two
Cameroonian towns
Jane-Francis Tatah Kihla Akoachere1,2*, Suylika Yvonne1, Njom Henry Akum2 and Esemu Nkie Seraphine2Abstract
Background: Urinary tract infection (UTI) represents one of the most common diseases encountered in community
medical practice. In resource poor settings, treatment is usually empiric due to the high cost and long duration
required for reporting diagnosis by culture and antibiotic susceptibility testing. With the growing problem of drug
resistance knowledge of antibiotic susceptibility pattern is pertinent for successful eradication of invading
pathogens. Our study, the first of its kind in Cameroon, analyzed the distribution and antibiotic susceptibility of
bacteria causing community-acquired urinary tract infection (CAUTI) in two towns (Bamenda and Buea) with a large
number of young and middle aged persons, to provide data that could guide empiric treatment.
Findings: We cultured 235 urine specimens and analyzed the antibiotic susceptibility of isolates by the disc
diffusion technique. Uropathogens were recovered from 137 (58.3%), with prevalence rates in Buea and Bamenda
being 65.9% and 54% respectively. Predominant pathogens were Escherichia coli (31.4%), Klebsiella oxytoca (25.5%)
and Staphylococcus spp (24.1%). Geographic variation in uropathogen distribution and antibiotic susceptibility was
observed, and a significant difference in pathogen distribution with respect to gender. The 20–39 years age group
had the highest prevalence of infection. All pathogens isolated were detected in this group. Isolates exhibited low
susceptibility to antibiotics tested. Bamenda isolates generally exhibited lower susceptibility compared to those
from Buea.
Conclusion: Regional variation in etiology of CAUTI and antibiotic susceptibility observed in our study emphasizes
the need to establish local and national antimicrobial resistance monitoring systems in Cameroon to provide
information for the development of CAUTI treatment guidelines.
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A total of 235 patients comprising 150 (63.8%) from
Bamenda and 85 (36.2%) from Buea were sampled. Of
these, 167 (71.1%) were females and 68 (38.9%) were
males. The age of participants ranged from 2 years to
80 years. Patients were stratified into the following age-
groups: < 20 years (n = 29, 12.3%), 20–39 years (n = 131,
55.7%), 40–59 years (n = 51, 21.7%) and ≥ 60 years* Correspondence: jakoachere@yahoo.com
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distribution, and reproduction in any medium(n = 24, 10.2%). A total of 137 (58.3%) samples had sig-
nificant growth of pathogens.
UTI prevalence was 65.9% in Buea and 54% in
Bamenda (Table 1). Logistic regression analysis of UTI
with study site as a predictor produced no significant re-
lationship (G= 0.161, df = 1, p= 0.687). Measure of asso-
ciation between prevalence of UTI and study site
showed weak predictive ability (Somers’ D (0.01) and
Goodman-Kruskal Gamma (0.11) are close to zero).
Analyzing prevalence with respect to gender, females
(67.7%) had a higher prevalence of infection than males
(35.3%) (Table 1). UTI prevalence was significantly
related to gender (G= 20.769, DF = 1, P-Value = 0.000)
with projections of 1.346 higher prevalence in femalestral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Prevalence of infection in study area with respect
to gender
Study Site (Region) Gender No. positive % positive
Bamenda(North West) Females, n = 97 65 67.0%
Males, n = 53 16 30.2%
Total 150 81 54.0%
Buea(South West) Females, n = 70 48 68.6%
Males , n =15 8 53.3%
Total 85 56 65.9%
Grand total Females, n = 167 113 67.7%
Males, n = 68 24 35.3%
Males + females = 235 137 58.3%
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Goodman-Kruskal Gamma (0.59) were associated with
this relationship indicating good predictive ability. A
combined logistic regression using gender, study site ver-
sus UTI showed a significant relationship (G= 23.419,
DF = 2, P-Value = 0.000) and good predictive power
(Somers’ D (0.29), Goodman-Kruskal Gamma (0.58)).
E. coli (31.4%), K. oxytoca (25.5%) and Staph. sp
(24.1%) were the predominant isolates associated with UTI
while K. pneumoniae had the least occurrence (1/81, 1.2%)
(Figure 1).
Gram-positive organisms constituted only 26.3% of
isolates (Table 2). Klebsiella oxytoca was the most fre-
quently isolated organism in Bamenda (29.6%). This wasFigure 1 Prevalence of bacterial isolates in samples. Ten bacterial spec
predominant pathogens isolated while K. pneumoniae was the least.closely followed by E. coli (28.4%) and Staph. spp
(22.2%). The predominant pathogen in Buea was E. coli
(35.7%). Streptococcus spp. (3/56, 5.4%) were isolated
only from samples from Buea while Proteus vulgaris
(4/81, 4.9%) and K. pneumoniae (1/81, 1.2%) were
detected only in samples from Bamenda. There was no
significant relationship between uropathogen distribu-
tion and study site (G = 1.665, DF = 1, P-Value = 0.197).
Citrobacter freundii, K. pneumoniae and Serratia
marcescens were isolated only from female participants
(Figure 2). Predominant pathogens in females were E.
coli (88.4%), Enterobacter cloacae (85.7%) and K. oxytoca
(80%) (Figure 2). In males the most frequently isolated
organisms were Strep. spp (33.3%), Pseudomonas aeruginosa
(28.6%) and P. vulgaris (25.0%). All bacteria isolated from
males were also isolated from females.
E. coli, E. cloacae, K. oxytoca and Staph. spp were iso-
lated from all age-groups (Table 3). All isolates were
detected in the 20–39 years group. With the exception
of the 40–59 years group in which the predominant iso-
late was K. oxytoca (40.7%), E. coli was the predominant
isolate in all the other age groups. In addition to E. coli
(26.7%), other predominant isolates in the< 20 years
participants were K. oxytoca (26.7%) and Staph. spp
(26.7%). K. pneumoniae (1.2%) was isolated solely from
20–39 years age-group. Strata of age gave insufficient
evidence for a significant relationship with uropathogens
(G= 0.824, DF = 3, P-Value = 0.844). However, the logistic





ies were isolated.E. coli, K. oxytoca and Staph. spp were the
Table 2 Distribution of uropathogens in study sites
Isolate Bamenda (%) Buea(%) Total (%) Gram reaction
E. coli 23 (28.4 )* 20 (35.7 )* 43 (31.4 ) Gram-negative
n = 101 (73. 7%)K. oxytoca 24 (29.6) 11 (19.6) 35 (25.5)
E. cloacae 5 (6.2) 2 (1.8) 7 (5.1)
Ps. aeruginosa 3 (3.7) 3 (5.4) 6 (4.4)
P. vulgaris 4 (4.9) 0 (0.0)** 4 (2.9)
S. marcescens 2 (2.5) 1 (1.8) 3 (2.2)
C. freundii 1 (1.2) 1 (1.8) 2 (1.5)
K. pneumoniae 1 (1.2) 0 (0.0)** 1 (0.7)
Staph. spp 18 (22.2) 15 (26.8) 33 (24.1) Gram-positive
n = 36 (26.3%)Strep. spp 0 (0.0)** 3 (5.4) 3 (2.2)
Total 81 (59.1) 56 (40.9) 137 (100)
*Most prevalent isolate in study site; **Isolated not recovered from study site.
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uropathogens distribution order of 60 +< (< 20)< (40–
59)< (20–39). Both the Pearson and Deviance tests had













































Figure 2 Distribution of uropathogens with respect to gender. Prevale
from males were detected in females. C. fruendii, Klebsiella pneumoniae andindicating that there was insufficient evidence for the
model not fitting the data adequately.
Antimicrobial susceptibility of isolates
The antimicrobial potency and spectrum of 8 classes of
antibiotics against uropathogens is summarized in
table 4. Cotrimoxazole was the most inactive drug as
isolates showed very low susceptibilities: 12.5% for Buea
and 1.9% for Bamenda. However, all (100%) E. coli iso-
lates from Buea were sensitive to the drug. Isolates were
also resistant to ampicillin and nitrofurantoin. E. coli iso-
lates from Bamenda were most sensitive to ceftriaxone
(65%) (Table 4). All K. oxytoca isolates from Buea were
sensitive to ciprofloxacin (100%) and gentamicin (100%)
whereas the most potent drugs against the Bamenda iso-
lates were gentamicin (91.2%), ciprofloxacin (87.5%) and
nitrofurantoin (83.3%). Isolates generally exhibited sus-
ceptibility greater than 50% to ciprofloxacin except for S.
marcescens, Strep. spp and E. cloacae from Buea, and C.

























nce of pathogens was higher in females than in males. All isolates
Serratia marcescens were isolated only from female participants.
Table 3 Distribution of isolates with respect to age of
participants
Isolate Age-group
< 20 (%) 20–39 (%) 40–59 (%) ≥ 60 (%) Total (%)
E. coli 4 (26.7)* 29 (35.8)* 5 (18.5) 5 (35.7)* 43 (31.4)
K. oxytoca 4 (26.7)* 17 (21) 11 (40.7)* 3 (21.4) 35 (25.5)
Staph. spp 4 (26.7)* 18 (22.2) 6 (22.2) 4 (28.6) 33 (24.1)
E. cloacae 1 (6.7) 4 (4.9) 1 (3.7) 1 (7.1) 7 (5.1)
Ps. aeruginosa 0** 3 (3.7) 2 (7.4) 1 (7.1) 6 (4.4)
P. vulgaris 0** 3 (3.7) 1 (3.7) 0** 4 (2.9)
S. marcescens 0** 2 (2.5) 1 (3.7) 0** 3 (2.2)
Strep. Spp 1 (6.7) 2 (2.5) 0** 0** 3 (2.2)
C. freundii 1 (6.7) 1 (1.2) 0** 0** 2 (1.5)
K. pneumoniae 0** 1 (1.2) 0** 0** 1 (0.7)
Total 15 (10.9) 81 (59.1) 27 (19.7) 14 (10.2) 137 (100)
*Most prevalent pathogen in age group; **Pathogen not detected in age
group.
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to gentamicin (80.9%) whereas ciprofloxacin (65.0%) was
the most active agent against Bamenda isolates. With a
few exceptions, Bamenda isolates generally exhibited
lower susceptibilities than Buea isolates.
Background
Urinary tract infection (UTI) is the second most common
infectious presentation in community medical practice.
Worldwide, about 150 million people are diagnosed with
UTI each year costing the global economy in excess of 6 bil-
lion dollars [1]. The incidence of these infections among
young sexually active women has been reported to exceed
0.5 episodes per year [2] with 20 to 30% of women experien-
cing recurring infections. During reproductive life this infec-
tion represents a great amount of work disabilities, hence
the need for prophylaxis and prompt treatment. Most of the
UTI seen in women are uncomplicated (occurring in other-
wise healthy individuals without any metabolic, functional
or anatomic abnormality of the urinary tract). However, after
middle age, the prevalence and incidence of UTI increase
progressively in men with a concomitant and progressive
decrease in the male-to-female ratio [3]. Major contributing
factors for high levels of UTIs particularly in rural areas are
poor sanitary conditions and lack of proper hygiene.
Reporting of antimicrobial susceptibility testing of the
urinary tract is usually achieved 48 h following sampling,
and therefore, in the majority of community-acquired
UTI (CAUTI), treatment decision is empiric, based on
the limited and predictable spectrum of etiological
microorganisms and available data reflecting antibiotic
resistance. Furthermore, in most cases, culture and sus-
ceptibility testing costs more than antibiotic treatment
itself. These factors have complicated empiric treatment
of CAUTI as data on uropathogens prevalence andantimicrobial susceptibility becomes more difficult to
obtain. Considering the fact that as with many commu-
nity-acquired infections, resistance rates to antimicro-
bials commonly used in treatment of UTI is increasing
and susceptibility of microorganisms shows significant
geographical variations [4], studies to increase know-
ledge on etiologic agents of UTIs and their resistance
patterns to antibiotics at the local and national levels are
very important to guide clinicians in empiric treatment.
The etiology and resistance pattern of community-
acquired uropathogens has not been extensively studied
in Cameroon. Due to the high cost associated with diag-
nosis of UTI by culture, laboratory diagnosis of UTI in
most health care facilities is mainly by urinalysis and
urine microscopy. Although the etiology of UTI is pre-
dictable, determination of antimicrobial susceptibility
pattern of pathogens is unattainable with these techni-
ques. Therefore treatment of UTI is mainly empiric,
without knowledge of antibiotic susceptibility of invad-
ing pathogen. With the growing problem of drug resist-
ance in Cameroon as demonstrated by recent studies
[5,6] there is an urgent need for continuous surveillance
of antibiotic susceptibility of uropathogens. Appropriate
knowledge of local and national antimicrobial resistance
trends is of utmost importance in order to step up evi-
dence based recommendations in empiric antibiotic
treatment of UTI. Data on etiology of UTI as well as
local and national antimicrobial susceptibility of uro-
pathogens in Cameroon is scarce. This study was aimed
at analyzing the distribution of species of bacterial
pathogens associated with community-acquired UTI in
patients in two Cameroonian towns: Bamenda (North
West region) and Buea (South West region) and to de-
termine their susceptibility to commonly prescribed
antibiotics so as to generate data that could be helpful in
improving the efficacy of empiric treatment of UTI.
These towns were selected because of their location in
distinct geographic regions and also because they host
many educational institutions and as such have a large
number of young and middle age individuals. Findings




The study was carried out in Bamenda and Buea.
Bamenda is the capital city of North West (NW) region
and has a population of over 269,530. It is characterized
by high relief, cool temperatures (particularly in the dry
season), heavy rainfall and savanna vegetation. Buea, the
capital of the South West (SW) region is located on the
eastern slopes of Mount Cameroon and has a population
of over 200,000. Because of its location at the foot of
Mount Cameroon, it has tropical and mountain















E. coli 93.3 26.1 100 52.2 100 17.4 100 39.1 80 43.5 20 43.5 35 65
K. oxytoca 36.4 36.4 100 87.5 0 0 0 29.2 100 91.2 90.9 83.3 18.2 75
Staph. sp 40 77.7 80 55.6 0 0 33.3 55.6 66.7 55.6 40 66.7 53.3 72.2
E. cloacae 100 0 0 80 0 0 100 50 100 80 0 80 100 100
P. aeruginosa 0 66.7 100 100 0 0 0 0 100 100 100 66.7 66.7 100
P. vulgaris ND 0 ND 50 ND 0 ND 50 ND 25 ND 50 ND 25
S. marcescens 0 50 0 100 0 0 100 0 100 100 0 50 0 50
Strept. spp 100 ND 0 ND 0 ND 100 ND 100 ND 0 ND 100 ND
C. fruendii 0 0 100 0 0 0 0 100 0 100 0 0 0 0
K. pneumoniae ND 0 ND 100 ND 0 ND 0 ND 0 ND 0 ND 0
Mean % 46.2 28.5 60 65.0 12.5 1.9 54.2 36.0 80.8 55.1 31.4 48.9 46.7 54.1
BU- Buea; BD-Bamenda; ND-Not determined as isolate was not recovered from study site; AMP-Ampicillin; CIP-Ciprofloxacin; COT-Cotrimoxazole;
ERY-Erythromycin; GEN- Gentamicin; NIT- Nitrofurantoin; CEF- Ceftriaxone.
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humid. Extended periods of rainfall, characterized by in-
cessant drizzle and damp fogs are common during the
rainy season. Buea and Bamenda are located 222 km
apart.
Study design, data collection and patients
This study was based on laboratory investigations with
urine samples collected from all hospitalized and outpa-
tients (those for which urinalysis was requested) in
selected hospitals in Bamenda and Buea between 01
March, 2009 and 28 February, 2010. Participating hospi-
tals were chosen due good patient turn out. The study
included all patients having clinical evidence of UTI with
symptoms less than 7 days presenting at the out-patient
department of hospitals and those admitted for less than
48 h. All patients sampled gave consent to participate in
the study. Patients with pregnancy, complicating factors
such as upper UTI, urinary abnormalities or more than
three episodes of UTI in the previous year were
excluded. Also excluded from this study were patients
with clinical symptoms of UTI but whose samples
showed no growth and those who underwent antibiotic
treatment within 48 h. Patients’ demographic data,
symptoms and physical examination were collected
using a questionnaire. Only one sample was collected
from each patient. Ethical approval of the study was
obtained from participating hospitals (Bamenda Regional
Hospital, St. Mary Health Center Bamenda, Regional
Hospital Annex Buea and Mount Mary Health Center
Buea) and from the Northwest and Southwest Regional
Delegations of Public Health.
Sample collection and analysis
Fifty milliliters of clean-catch midstream urine specimen
was collected in a sterile Dynarex specimen container.Twenty-five milliliters was used in this study and the
rest of the sample was used by the hospital laboratory
for urinalysis. The semi-quantitative technique to deter-
mine significant bacteriuria was employed by using
0.01 mL calibrated wire loop to inoculate 5% blood agar
and Eosine-Methylene Blue (EMB) agar with uncentri-
fuged urine. Culture plates were incubated at 37°C for
18–24 h. After inoculation of media, the remaining sam-
ple was centrifuged at 2000 rpm for 5 minutes and sedi-
ment used for microscopy. A specimen was considered
positive if a single organism was isolated at a concentra-
tion of greater than105 CFU/mL and associated with mi-
croscopy findings of greater than 10 leucocytes per high
power field. Bacteria were identified by Gram’s stain and
standard biochemical procedures. Identity of enterobac-
teriaceae was confirmed using the API 20E kit.
Antibiotic susceptibility testing
Susceptibility of isolates to antimicrobial agents of differ-
ent classes was assessed by the disk diffusion technique
on Mueller-Hinton agar as described by the National
Committee for Clinical Laboratory Standards (presently
called Clinical Laboratory Standard Institute) [7]. The
following antibiotics used for empiric treatment were ana-
lyzed: erythromycin (15 μg/mL), gentamicin (10 μg/mL),
trimethoprim/sulfamethoxazole (2.5 μg/mL), nitrofurantoin
(50 μg/mL), ampicillin (25 μg/mL), ceftriazone (10 μg/mL),
ciprofloxacin (5 μg/mL) and pefloxacin (10 μg/mL) (Oxoid,
Basingstoke, England).
Statistical analysis
Data from study was inserted into two separate MS
Excel spreadsheets that were later on merged to ensure
correct data entry, coded and imported into Minitab 16
for statistical analysis. Logistic regression was used to
test the relationship between predictors (variables in the
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of the G statistics at an α-level of 0.05. Coefficients of
factor levels were used for comparative analysis relative
to reference factors. Goodness-of-fit statistics was used
to compare the fits of different models. Measure of asso-
ciation was used between predicted probabilities and the
response variable to test the predictive ability of the
model. Descriptive statistics was employed to weigh the
outcome of variables.
Discussion
Urinary tract infections (UTIs) represent one of the
most common diseases encountered in medical practice,
causing significant associated morbidity and occurring
from neonate to the elderly [8]. Studies [9] have demon-
strated geographic variation in etiologic characteristics
of UTI and their resistance patterns to antibiotics.
Therefore to successfully eradicate UTI by empiric treat-
ment, knowledge of local etiologic agents and their anti-
biotic susceptibility is of great value. This study reports
the etiologic agents of CAUTI and their antibiotic sus-
ceptibility in two Cameroonian cities located 222 km
apart in two distinct geographic regions, and provides
baseline data which could help in the establishment of
local guidelines for treatment of CAUTI. Patients
sampled were from the communities where the partici-
pating hospitals serve as main primary care centers.
Of the 235 suspected cases of UTI that were positive
by microscopy (greater than 10 leucocytes per high
power microscope field), only 137 (58.3%) were positive
by culture (Table 1). Although the presence of white
blood cells in urine signifies inflammation, based on our
results, they do not always indicate UTI. Our findings
therefore indicate that urine culture is essential for de-
finitive diagnosis of UTI. The prevalence rate in Buea
(65.9%) was higher than 54.0% recorded in Bamenda. In
a similar study in Buea, Assob et al. [10] analyzed 53
urine samples from patients with UTI and reported a
prevalence rate of 49.06%. Logistic regression analysis
showed no relationship between UTI prevalence and
study site (G = 0.161, df = 1, p= 0.687). Values reported
in our study are higher than 35.2% reported by Yuyun
et al. [11] in Yaounde, Cameroon. Prevalence rates
reported in Cameroon are higher than values reported
in other developing countries such as Senegal, 8.45%
[12], Cambodia 22.53% [13], Latin America 29.9% [14],
Rwanda, 19.3% [15] and India 10.86% [16] and 9.17%
[17]. Thus UTI could be a significant cause of morbidity
in Cameroon. Although UTI ranks among the most
common infections in developing countries we sampled
only 235 participants. In addition to the fact that un-
complicated UTIs are generally self-limiting, patients are
usually concerned about the social stigma associated
with UTI as such prefer unorthodox treatment or selfmedication. These factors could explain our small sam-
ple size.
UTI prevalence was higher in females (67.7%) than in
males (35.3%) (Table 1). The prevalence of UTI was sig-
nificantly related to gender (G = 20.769, DF = 1, P-
Value = 0.000). The highest occurrence was in the age
group 20–39 years (81/137, 59.1%) followed by partici-
pants 40–59 years old (27/137, 19.7%) (Table 3). This is
in agreement with previous studies [16] which have
demonstrated a high prevalence of UTI in individuals
less than 50 years of age. However, recent studies [18]
have associated older age with higher morbidity. The age
group 20–39 years is the most sexually active group of
the population and their activities predispose them to
UTI. Most women of child-bearing age fall within this
group. Thus, during reproductive life, UTI could cause a
great amount of disabilities. The propensity of young
women to develop UTI has been explained on the basis
of their anatomy (especially a short urethra) and certain
behavioral factors [19].
Gram negative organisms (73.7%) (Table 2) were the
main cause of UTI in our study sites with E. coli (31.4%)
being the predominant pathogen while K. pneumoniae
was the least (1.2%) (Figure 1). UTI etiology as well as
the predominance of E. coli as a leading cause of CAUTI
reported in our study has been well documented in
reports from other parts of the world such as the ECO
SENS report from Europe and Canada [20], and The
Surveillance Network (TSN) study from the United
States [21] as well as numerous reports from developing
countries [22,23]. The low prevalence of K. pneumoniae
in cases of CAUTI is consistent with previous studies
[24]. Although E. coli, K. oxytoca and Staph. spp were
the principal uropathogens in our study sites, there was
a remarkable variation in distribution of other etiologic
agents between study sites. P. vulgaris (4.9%) and K.
pnuemoniae (1.2%) were isolated only from samples col-
lected from Bamenda whereas Strep. spp (5.4%) was
detected solely in Buea samples. Even though the preva-
lence of these isolates was low, our data suggests evolu-
tion in uropathogen etiology and emphasizes the need
for periodic assessment of uropathogens and their anti-
biotic susceptibility pattern at local and national level to
guarantee successful empiric treatment. Due to the large
number of isolates obtained from this study, we were
unable to characterize the Gram positive isolates to per-
mit their identification to species level. This constitutes
a limitation to this study. All uropathogens predomi-
nated in females than in males (Figure 2). In addition we
observed variation in distribution of etiologic agents
with gender and age (Figure 2, Table 3). C. fruendii, K.
pneumoniae and S. marcescens were isolated solely from
females. All isolates were recovered from the age group
20–39 years whereas in participants over 60 years old,
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gave insufficient evidence for a significant relationship
with uropathogens (G= 0.824, DF = 3, P-Value = 0.844).
However, the logistic regression coefficient of age strata;
0.040, -0.296, 0.038 for 20–39, 40–59, 60+ respectively
showed an increasing uropathogens distribution order of
60 +< (< 20)< (40–59)< (20–39).
Our data demonstrates low susceptibility to first line
agents and regional variation in antibiotic susceptibility
pattern. Generally, ampicillin, cotrimoxazole and nitro-
furantoin were the most inactive drugs as they exhibited
susceptibilities less than 50% in both study sites. These
low susceptibilities limit their usefulness in the treat-
ment of UTI. All isolates were resistant (100%) to cotri-
moxazole except E. coli with susceptibilities of 100% and
17.4% respectively for the Buea and Bamenda isolates.
Other studies on community-acquired UTI [16] have
reported low susceptibility of E. coli to cotrimoxazole.
Although the Infectious Disease Society of America
(IDSA) guidelines consider cotrimoxazole for empiric
treatment of UTI [25], the low susceptibility recorded in
our study (12.5% and 1.9% respectively for Buea and
Bamenda isolates) shows that cotrimoxazole is not ap-
propriate for empiric treatment of UTI in study sites but
could be a suitable agent for eradication of E. coli infec-
tions in Buea. Susceptibility of E. coli to other antibiotics
was lower than reported in other African countries
[26,27]. K. oxytoca generally showed low susceptibility to
antibiotics with the exception of ciprofloxacin, gentami-
cin and nitrofurantoin with susceptibilities more than
87% in both study sites. For Staph spp, ciprofloxacin
(80%) was most effective against Buea isolates while for
the Bamenda isolates, ampicillin (77.7%) and ceftriaxone
(72.2%) were the most potent agents. We did not include
a control strain in susceptibility testing. In addition, we
did not determine the minimum inhibitory concentra-
tion (MIC) of potent antibiotics. These are other limita-
tions to this study. The most inactive drugs were
ampicillin, cotrimoxazole and nitrofurantoin with overall
susceptibilities <50%. Higher susceptibilities to these
drugs have been reported in Europe [28]. Low suscepti-
bilities recorded in our study could be due to the fact
that these antibiotics have been extensively used in the
treatment of community-acquired UTIs and other infec-
tions in the past years in these regions. Most antibiotics
tested are oral antibiotics which usually achieve high
urinary concentrations and are therefore believed to be
potent. Low susceptibilities observed indicate the need
for antibiotic susceptibility testing to circumvent treat-
ment failure. Although no reliable data exists, it is well
known that many persons in study sites self-medicate,
suggesting uncontrolled consumption of these anti-
microbial agents particularly as they are cheap. Further-
more the implementation of policy on sale of antibioticsin study sites is weak: many unauthorized persons sell
drugs and in pharmacies sale is not restricted exclusively
to those with prescription. These factors could contrib-
ute to emergence of resistance. The IDSA guideline
recommends a bench mark of 10–20% resistance at
which first-line empiric therapy should be modified [25].
Thus, gentamicin with an overall susceptibility of 80.8%
could be appropriate for empiric treatment of UTI in
Buea. Most hospitals in study sites are small and usually
do not admit patients who are not critically ill. Out-
patients prescribed treatments with drugs such as genta-
micin which is formulated as injection either return to
the hospital for treatment as required or they get assist-
ance from trained nurse in their neighborhood. None of
the antibiotics tested is suitable for use in empiric eradi-
cation of UTIs in Bamenda. Thus urine cultures are ne-
cessary since treatment failure with empiric therapy is
likely to occur. In addition studies with other antibiotics
not included in our investigation may establish effective
agent (s) against Bamenda isolates.
Conclusion
Our findings demonstrate regional variation in UTI eti-
ology as well as their antibiotic susceptibility emphasiz-
ing the need to establish local and national antimicrobial
resistance monitoring systems in Cameroon to provide
information for the development of CAUTI treatment
guidelines. To the best of our knowledge, this is the first
report in Cameroon that describes the etiology of com-
munity-acquired UTI and their antibiotic susceptibility
in two distant localities.
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